{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T13:29:41Z","timestamp":1780579781547,"version":"3.54.1"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T00:00:00Z","timestamp":1710374400000},"content-version":"am","delay-in-days":287,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000025","name":"NIMH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.jad.2023.02.152","type":"journal-article","created":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T11:05:42Z","timestamp":1678532742000},"page":"227-238","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Efficacy and adverse effects of ketamine versus electroconvulsive therapy for major depressive disorder: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"330","author":[{"given":"Debora","family":"de A. Simoes Moreira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu\u00eds Eduardo","family":"Gauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilherme","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda Carolina","family":"Fonseca da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Cavalcanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o","family":"Quevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2023.02.152_bb0005","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.biopsych.2009.08.038","article-title":"Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression","volume":"67","author":"aan het Rot","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2023.02.152_bb0010","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jad.2015.06.033","article-title":"Serum BDNF as a peripheral biomarker of treatment-resistant depression and the rapid antidepressant response: a comparison of ketamine and ECT","volume":"186","author":"Allen","year":"2015","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2023.02.152_bb0015","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.jpsychires.2022.04.037","article-title":"Real-world effectiveness of ketamine in treatment-resistant depression: a systematic review & meta-analysis","volume":"151","author":"Alnefeesi","year":"2022","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2023.02.152_bb0020","series-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"2013"},{"key":"10.1016\/j.jad.2023.02.152_bb0025","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.22f14451","article-title":"Insights for the use of ketamine from randomized controlled trials that compared ketamine with electroconvulsive therapy in severe depression","volume":"83","author":"Andrade","year":"2022","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2023.02.152_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jpsychires.2020.01.002","article-title":"Antidepressant and neurocognitive effects of serial ketamine administration versus ECT in depressed patients","volume":"123","author":"Basso","year":"2020","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2023.02.152_bb0035","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2023.02.152_bb0040","series-title":"Comprehensive Textbook of Psychiatry","first-page":"755","article-title":"Psychiatric rating scales","volume":"7","author":"Blacker","year":"2005"},{"key":"10.1016\/j.jad.2023.02.152_bb0045","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/nau.24341","article-title":"What urologists need to know about ketamine-induced uropathy: a systematic review","volume":"39","author":"Castellani","year":"2020","journal-title":"Neurourol. Urodyn."},{"key":"10.1016\/j.jad.2023.02.152_bb0050","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s40263-021-00846-5","article-title":"Prevention and management of common adverse effects of ketamine and esketamine in patients with mood disorders","volume":"35","author":"Ceban","year":"2021","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jad.2023.02.152_bb0055","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1757-5672.2011.00101.x","article-title":"Ketamine-induced uropathy: a new clinical entity causing lower urinary tract symptoms","volume":"4","author":"Chang","year":"2012","journal-title":"LUTS: Low. Urin. Tract Symptoms"},{"key":"10.1016\/j.jad.2023.02.152_bb0060","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1756-185X.2012.01712.x","article-title":"Conducting a meta-analysis: basics and good practices","volume":"15","author":"Cheung","year":"2012","journal-title":"Int. J. Rheum. Dis."},{"key":"10.1016\/j.jad.2023.02.152_bb0065","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1111\/j.1464-410X.2008.07920.x","article-title":"The destruction of the lower urinary tract by ketamine abuse: a new syndrome?","volume":"102","author":"Chu","year":"2008","journal-title":"BJU Int."},{"key":"10.1016\/j.jad.2023.02.152_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2021.114321","article-title":"Frequency analysis of symptomatic worsening following ketamine infusions for treatment resistant depression in a real-world sample: results from the Canadian rapid treatment center of excellence","volume":"307","author":"Di Vincenzo","year":"2022","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2023.02.152_bb0075","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.4088\/JCP.09m05327blu","article-title":"Rapid resolution of suicidal ideation after a single infusion of an N -methyl- D -aspartate antagonist in patients with treatment-resistant major depressive disorder","volume":"71","author":"DiazGranados","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2023.02.152_bb0080","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/ijnp\/pyab088","article-title":"Racemic ketamine as an alternative to electroconvulsive therapy for unipolar depression: a randomized, open-label, non-inferiority trial (KetECT)","volume":"25","author":"Ekstrand","year":"2022","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2023.02.152_bb0085","series-title":"The ECT Handbook","year":"2020"},{"key":"10.1016\/j.jad.2023.02.152_bb0090","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1007\/s00213-014-3664-5","article-title":"Ketamine administration in depressive disorders: a systematic review and meta-analysis","volume":"231","author":"Fond","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jad.2023.02.152_bb0095","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.psychres.2013.12.008","article-title":"Rapid antidepressant effects of repeated doses of ketamine compared with electroconvulsive therapy in hospitalized patients with major depressive disorder","volume":"215","author":"Ghasemi","year":"2014","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2023.02.152_bb0100","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.14228","article-title":"Effect of ketamine on cardiovascular function during procedural sedation of adults","author":"Goddard","year":"2021","journal-title":"Cureus."},{"key":"10.1016\/j.jad.2023.02.152_bb0105","first-page":"4","article-title":"The enigma of the stigma of ECT: 50 years of myth and misrepresentation","volume":"88","author":"Hay","year":"1989","journal-title":"Wis. Med. J."},{"key":"10.1016\/j.jad.2023.02.152_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109299","article-title":"The therapeutic role of ketamine and esketamine in treating psychopathological domains of depression","volume":"223","author":"Jawad","year":"2023","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jad.2023.02.152_bb0115","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/acps.13134","article-title":"When to consider electroconvulsive therapy (ECT)","volume":"141","author":"Kellner","year":"2020","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jad.2023.02.152_bb0120","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/JCP.0000000000001289","article-title":"Comparison of rapid antidepressant and antisuicidal effects of intramuscular ketamine, oral ketamine, and electroconvulsive therapy in patients with major depressive disorder: a pilot study","volume":"40","author":"Kheirabadi","year":"2020","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2023.02.152_bb0125","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4103\/abr.abr_166_18","article-title":"Comparative effect of intravenous ketamine and electroconvulsive therapy in major depression: a randomized controlled trial","volume":"8","author":"Kheirabadi","year":"2019","journal-title":"Adv. Biomed. Res."},{"key":"10.1016\/j.jad.2023.02.152_bb0130","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1002\/sim.1482","article-title":"Improved tests for a random effects meta-regression with a single covariate","volume":"22","author":"Knapp","year":"2003","journal-title":"Stat. Med."},{"key":"10.1016\/j.jad.2023.02.152_bb0135","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000338098","article-title":"Ketamine-associated urinary tract dysfunction: an underrecognized clinical entity","volume":"89","author":"Lai","year":"2012","journal-title":"Urol. Int."},{"key":"10.1016\/j.jad.2023.02.152_bb0140","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.jpsychires.2022.04.035","article-title":"The abuse liability of ketamine: a scoping review of preclinical and clinical studies","volume":"151","author":"Le","year":"2022","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2023.02.152_bb0145","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/brb3.37","article-title":"Contemporary use and practice of electroconvulsive therapy worldwide","volume":"2","author":"Leiknes","year":"2012","journal-title":"Brain Behav."},{"key":"10.1016\/j.jad.2023.02.152_bb0150","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1002\/hbm.24895","article-title":"Modulation of amygdala reactivity following rapidly acting interventions for major depression","volume":"41","author":"Loureiro","year":"2020","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.jad.2023.02.152_bb0155","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.jad.2020.06.050","article-title":"The effect of intravenous, intranasal, and oral ketamine in mood disorders: a meta-analysis","volume":"276","author":"McIntyre","year":"2020","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2023.02.152_bb0160","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.expneurol.2009.04.027","article-title":"Antidepressant electroconvulsive therapy: mechanism of action, recent advances and limitations","volume":"219","author":"Merkl","year":"2009","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.jad.2023.02.152_bb0165","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.acn.2004.03.010","article-title":"Detecting depression in Alzheimer\u2019s disease: evaluation of four different scales","volume":"20","author":"Mullerthomsen","year":"2005","journal-title":"Arch. Clin. Neuropsychol."},{"key":"10.1016\/j.jad.2023.02.152_bb0170","doi-asserted-by":"crossref","first-page":"414","DOI":"10.4088\/JCP.10l06447blu","article-title":"A case of sustained remission following an acute course of ketamine in treatment-resistant depression","volume":"72","author":"Murrough","year":"2011","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2023.02.152_bb0175","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s00213-021-05767-1","article-title":"Ketamine-induced urological toxicity: potential mechanisms and translation for adults with mood disorders receiving ketamine treatment","volume":"238","author":"Ng","year":"2021","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jad.2023.02.152_bb0180","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jad.2021.06.032","article-title":"Efficacy of ketamine and esketamine on functional outcomes in treatment-resistant depression: a systematic review","volume":"293","author":"Ng","year":"2021","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2023.02.152_bb0185","doi-asserted-by":"crossref","first-page":"273","DOI":"10.24869\/psyd.2018.273","article-title":"Challenges of treatment-resistant depression","volume":"30","author":"Pandarakalam","year":"2018","journal-title":"Psychiatr. Danub."},{"key":"10.1016\/j.jad.2023.02.152_bb0190","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1017\/S1092852920002187","article-title":"Effectiveness of intravenous ketamine in mood disorder patients with a history of neurostimulation","volume":"27","author":"Rodrigues","year":"2022","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jad.2023.02.152_bb0195","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3390\/ijerph15040771","article-title":"Predictors of response to ketamine in treatment resistant major depressive disorder and bipolar disorder","volume":"15","author":"Rong","year":"2018","journal-title":"IJERPH"},{"key":"10.1016\/j.jad.2023.02.152_bb0200","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report","volume":"163","author":"Rush","year":"2006","journal-title":"AJP"},{"key":"10.1016\/j.jad.2023.02.152_bb0205","series-title":"Kaplan & Sadock\u2019s Synopsis of Psychiatry: Behavioral Sciences\/clinical Psychiatry","author":"Sadock","year":"2015"},{"key":"10.1016\/j.jad.2023.02.152_bb0210","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.biopsych.2010.06.009","article-title":"Objective cognitive performance associated with electroconvulsive therapy for depression: a systematic review and meta-analysis","volume":"68","author":"Semkovska","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2023.02.152_bb0215","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.urology.2007.01.038","article-title":"Ketamine-associated ulcerative cystitis: a new clinical entity","volume":"69","author":"Shahani","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.jad.2023.02.152_bb0220","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jad.2020.07.066","article-title":"Antidepressant effects of ketamine and ECT: a pilot comparison","volume":"276","author":"Sharma","year":"2020","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2023.02.152_bb0225","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jpsychires.2021.03.009","article-title":"Antisuicidal and antidepressant effects of ketamine and esketamine in patients with baseline suicidality: a systematic review","volume":"137","author":"Siegel","year":"2021","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2023.02.152_bb0230","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1176\/appi.ajp.2016.16010037","article-title":"A double-blind, randomized, placebo-controlled, dose-frequency study of intravenous ketamine in patients with treatment-resistant depression","volume":"173","author":"Singh","year":"2016","journal-title":"AJP"},{"key":"10.1016\/j.jad.2023.02.152_bb0235","doi-asserted-by":"crossref","first-page":"d4002","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials","volume":"343","author":"Sterne","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.jad.2023.02.152_bb0240","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/ddr.430350314","article-title":"Psychopharmacology: the fourth generation of progress","volume":"35","author":"Sullivan","year":"1995","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.jad.2023.02.152_bb0245","doi-asserted-by":"crossref","first-page":"56","DOI":"10.4103\/0253-7176.96161","article-title":"Rapid antidepressant response with ketamine: is it the solution to resistant depression?","volume":"34","author":"Thakurta","year":"2012","journal-title":"Indian J. Psychol. Med."},{"key":"10.1016\/j.jad.2023.02.152_bb0250","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/acps.12721","article-title":"The mortality rate of electroconvulsive therapy: a systematic review and pooled analysis","volume":"135","author":"T\u00f8rring","year":"2017","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jad.2023.02.152_bb0255","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.3390\/ijerph16132255","article-title":"Indices of change, expectations, and popularity of biological treatments for major depressive disorder between 1988 and 2017: a scientometric analysis","volume":"16","author":"Tran","year":"2019","journal-title":"IJERPH"},{"key":"10.1016\/j.jad.2023.02.152_bb0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-2999(90)90204-J","article-title":"Functional antagonists at the NMDA receptor complex exhibit antidepressant actions","volume":"185","author":"Trullas","year":"1990","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jad.2023.02.152_bb0265","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.549080","article-title":"Meta-analysis: hemodynamic responses to sub-anesthetic doses of ketamine in patients with psychiatric disorders","volume":"12","author":"Vankawala","year":"2021","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.jad.2023.02.152_bb0270","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jad.2020.11.123","article-title":"Is ketamine an appropriate alternative to ECT for patients with treatment resistant depression? A systematic review","volume":"281","author":"Veraart","year":"2021","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2023.02.152_bb0275","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3102\/10769986030003261","article-title":"Bias and efficiency of meta-analytic variance estimators in the random-effects model","volume":"30","author":"Viechtbauer","year":"2005","journal-title":"J. Educ. Behav. Stat."},{"key":"10.1016\/j.jad.2023.02.152_bb0280","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2147\/NDT.S198774","article-title":"Management of treatment-resistant depression: challenges and strategies","volume":"16","author":"Voineskos","year":"2020","journal-title":"NDT"},{"key":"10.1016\/j.jad.2023.02.152_bb0285","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2023.02.152_bb0290","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1176\/appi.ajp.2016.15111401","article-title":"Critical appraisal of existing ketamine trials: existing limitations and limited applicability for treatment","volume":"173","author":"Zhang","year":"2016","journal-title":"AJP"},{"key":"10.1016\/j.jad.2023.02.152_bb0295","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12910-016-0087-3","article-title":"Is off-label repeat prescription of ketamine as a rapid antidepressant safe? Controversies, ethical concerns, and legal implications","volume":"17","author":"Zhang","year":"2016","journal-title":"BMC Med. Ethics"},{"key":"10.1016\/j.jad.2023.02.152_bb0300","article-title":"Ketamine\u2019s potential as a rapid antidepressant was overplayed","volume":"h4467","author":"Zhang","year":"2015","journal-title":"BMJ"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032723003245?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032723003245?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T03:54:38Z","timestamp":1759031678000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032723003245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":60,"alternative-id":["S0165032723003245"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2023.02.152","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and adverse effects of ketamine versus electroconvulsive therapy for major depressive disorder: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2023.02.152","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}